Journal Article
Treatment intensification with maraviroc (CCR5 antagonist) leads to declines in CD16-expressing monocytes in cART-suppressed chronic HIV-infected subjects and is associated with improvements in neurocognitive test performance: implications for HIV-associated neurocognitive disease (HAND)
Lishomwa C. Ndhlovu; Tracie Umaki; Glen M. Chew; Dominic C. Chow; Melissa Agsalda; Kalpana J. Kallianpur; Robert Paul; Guangxiang Zhang; Erika Ho; Nancy Hanks; Beau Nakamoto; Bruce T. Shiramizu; Cecilia M. Shikuma
Journal of NeuroVirology · Vol. 20, Issue 6 · pp. 571-582 · 2014